We've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreThis research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read moreOur study aims to understand how the severity modifier has been implemented so far and its impact on...
Read moreOur experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...
Read moreOur experts provide a detailed summary of Plenary Session 1 at ISPOR Annual 2023 on global affordabi...
Read moreOur research compares and contrasts the reimbursement landscapes of digital health applications (DHA...
Read moreOur experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...
Read moreIntroduction Real World Data is being increasingly used across the globe to support medical-product ...
Read more